Literature DB >> 24239921

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

David C Goff, Donald M Lloyd-Jones, Glen Bennett, Sean Coady, Ralph B D'Agostino, Raymond Gibbons, Philip Greenland, Daniel T Lackland, Daniel Levy, Christopher J O'Donnell, Jennifer G Robinson, J Sanford Schwartz, Susan T Shero, Sidney C Smith, Paul Sorlie, Neil J Stone, Peter W F Wilson.   

Abstract

Entities:  

Keywords:  ACC/AHA Practice Guideline; biomarkers; cardiovascular disease; cholesterol; primary prevention; risk assessment; risk reduction behavior

Mesh:

Substances:

Year:  2013        PMID: 24239921      PMCID: PMC4700825          DOI: 10.1016/j.jacc.2013.11.005

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  62 in total

1.  The next steps in developing clinical practice guidelines for prevention.

Authors:  Gary H Gibbons; John Gordon Harold; Mariell Jessup; Rose Marie Robertson; William J Oetgen
Journal:  J Am Coll Cardiol       Date:  2013-10-08       Impact factor: 24.094

2.  Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.

Authors:  Gary H Gibbons; Susan B Shurin; George A Mensah; Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2013-10-08       Impact factor: 24.094

3.  Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2013-09-03       Impact factor: 25.391

Review 4.  Heart disease and stroke statistics--2013 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2012-12-12       Impact factor: 29.690

5.  AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.

Authors:  Rita F Redberg; Emelia J Benjamin; Vera Bittner; Lynne T Braun; David C Goff; Stephen Havas; Darwin R Labarthe; Marian C Limacher; Donald M Lloyd-Jones; Samia Mora; Thomas A Pearson; Martha J Radford; Gerald W Smetana; John A Spertus; Erica W Swegler
Journal:  Circulation       Date:  2009-09-21       Impact factor: 29.690

6.  Systematic examination of the updated Framingham heart study general cardiovascular risk profile.

Authors:  Amanda K Marma; Donald M Lloyd-Jones
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

Review 7.  2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.

Authors:  Todd J Anderson; Jean Grégoire; Robert A Hegele; Patrick Couture; G B John Mancini; Ruth McPherson; Gordon A Francis; Paul Poirier; David C Lau; Steven Grover; Jacques Genest; André C Carpentier; Robert Dufour; Milan Gupta; Richard Ward; Lawrence A Leiter; Eva Lonn; Dominic S Ng; Glen J Pearson; Gillian M Yates; James A Stone; Ehud Ur
Journal:  Can J Cardiol       Date:  2013-02       Impact factor: 5.223

8.  Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.

Authors:  Satoru Kodama; Kazumi Saito; Shiro Tanaka; Miho Maki; Yoko Yachi; Mihoko Asumi; Ayumi Sugawara; Kumiko Totsuka; Hitoshi Shimano; Yasuo Ohashi; Nobuhiro Yamada; Hirohito Sone
Journal:  JAMA       Date:  2009-05-20       Impact factor: 56.272

9.  Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Authors:  Michael J Pencina; Ralph B D'Agostino; Martin G Larson; Joseph M Massaro; Ramachandran S Vasan
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

Review 10.  Improving assessment of cardiovascular disease risk by using family history: an integrative literature review.

Authors:  Mariam Kashani; Arn Eliasson; Marina Vernalis; Linda Costa; Mary Terhaar
Journal:  J Cardiovasc Nurs       Date:  2013 Nov-Dec       Impact factor: 2.083

View more
  860 in total

Review 1.  Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment.

Authors:  Yasushi Matsuzawa; Amir Lerman
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

Review 2.  Effects of stress on the development and progression of cardiovascular disease.

Authors:  Mika Kivimäki; Andrew Steptoe
Journal:  Nat Rev Cardiol       Date:  2017-12-07       Impact factor: 32.419

3.  Prediction of cardiovascular disease among hematopoietic cell transplantation survivors.

Authors:  Saro H Armenian; Dongyun Yang; Jennifer Berano Teh; Liezl C Atencio; Alicia Gonzales; F Lennie Wong; Wendy M Leisenring; Stephen J Forman; Ryotaro Nakamura; Eric J Chow
Journal:  Blood Adv       Date:  2018-07-24

Review 4.  Multimodality imaging for the prevention of cardiovascular events: Coronary artery calcium and beyond.

Authors:  Duygu Kocyigit; Alexandra Scanameo; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

5.  Cardiovascular Risk and Level of Statin Use Among Women With Breast Cancer in a Cardio-Oncology Clinic.

Authors:  Kelly Shum; Amber Solivan; Parham Parto; Nichole Polin; Eiman Jahangir
Journal:  Ochsner J       Date:  2016

6.  Basic vs More Complex Definitions of Family History in the Prediction of Coronary Heart Disease: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Jaideep Patel; Mahmoud Al Rifai; Maren T Scheuner; Steven Shea; Roger S Blumenthal; Khurram Nasir; Michael J Blaha; John W McEvoy
Journal:  Mayo Clin Proc       Date:  2018-03-16       Impact factor: 7.616

Review 7.  Assessing Cardiovascular Disease Risk and Responses to Preventive Therapies in Clinical Practice.

Authors:  Kevin C Maki; Mary R Dicklin
Journal:  Curr Atheroscler Rep       Date:  2018-03-20       Impact factor: 5.113

Review 8.  Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.

Authors:  Nivee P Amin; Seth S Martin; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Erin D Michos
Journal:  J Am Coll Cardiol       Date:  2014-05-07       Impact factor: 24.094

9.  Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients.

Authors:  C A Q Santos; D C Brennan; V J Fraser; M A Olsen
Journal:  Transplant Proc       Date:  2014-12       Impact factor: 1.066

Review 10.  Statins for Primary Prevention in Older Adults-Moving Toward Evidence-Based Decision-Making.

Authors:  Sonal Singh; Susan Zieman; Alan S Go; Stephen P Fortmann; Nanette K Wenger; Jerome L Fleg; Barbara Radziszewska; Neil J Stone; Sophia Zoungas; Jerry H Gurwitz
Journal:  J Am Geriatr Soc       Date:  2018-10-02       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.